Riptide Bioscience, Inc.
Riptide Bioscience is developing innovative peptide-based medicines with lifesaving potential, focusing on engineered Host Defense Peptides (HDPs) to combat microbial infections and moderate inflammation. Their mission is to create effective therapeutics for acute and chronic diseases by leveraging proprietary and patented peptide design strategies, supported by collaborations with academic institutions and government research programs.
Industries
Nr. of Employees
small (1-50)
Riptide Bioscience, Inc.
Patents
Products
Engineered peptide therapeutics for acute infection
Synthetic peptides derived from host-defense peptide structures designed for high-potency, broad-spectrum antimicrobial activity and biofilm penetration; intended for topical treatment of wounds, burns, and localized infections.
Engineered peptide therapeutics for inflammation modulation
Peptide candidates designed to moderate inflammatory responses and restore tissue balance in chronic inflammatory conditions.
Preclinical oncology peptide candidates
Designed lytic peptides with documented anticancer activity in preclinical studies intended for oncology indications.
Engineered peptide therapeutics for acute infection
Synthetic peptides derived from host-defense peptide structures designed for high-potency, broad-spectrum antimicrobial activity and biofilm penetration; intended for topical treatment of wounds, burns, and localized infections.
Engineered peptide therapeutics for inflammation modulation
Peptide candidates designed to moderate inflammatory responses and restore tissue balance in chronic inflammatory conditions.
Preclinical oncology peptide candidates
Designed lytic peptides with documented anticancer activity in preclinical studies intended for oncology indications.
Services
Collaborative preclinical research programs, government grant projects, and licensing of peptide technologies to external partners.
Collaborative preclinical research programs, government grant projects, and licensing of peptide technologies to external partners.
Expertise Areas
- Peptide therapeutic development
- Antimicrobial therapeutics
- Anti-inflammatory therapeutics
- Oncology therapeutics (peptide-based)
Key Technologies
- Synthetic peptide design and optimization
- Membrane-targeting antimicrobial mechanism
- Biofilm penetration assays
- In vitro antimicrobial and anticancer assays